Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Bilfinger Berger Buys Tebodin - Quick Facts

Bilfinger Berger (BFLBY.PK) said it has acquired Tebodin. The purchase price amounts to 145 million euros. Tebodin, which generates an annual output volume of 225 million euros and has 3,200 employees, is being sold by the Dutch Royal BAM Group.

Tebodin will serve as the basis for the establishment of a new Subgroup at Bilfinger Berger in the area of engineering and technologies. The company will be allocated to the Industrial Services reporting segment.

Bilfinger Berger is also applying its expertise in power plant technology to a joint venture with Tyazhmash, the Russian power plant outfitter. The newly-founded joint venture with power plant outfitter Tyazhmash has set itself the goal of playing a significant role in the required modernization of the Russian power plant network.

Bilfinger Berger holds a 51 percent stake in the new Bilfinger Babcock Tyazhmash.

Click here to receive FREE breaking news email alerts for Bilfinger Berger AG and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Stocks came under pressure in early trading on Friday and remained firmly in the red throughout the remainder of the trading session. With the losses on the day, the S&P 500 pulled back well off yesterday's record closing high. President Barack Obama is meeting with presidents from Central American nations on Friday as the U.S. struggles to deal with a surge of unaccompanied children across the southern border. Despite calls from some leading conservatives, the results of a new CNN/ORC International poll released Friday showed that a vast majority of Americans do not believe that President Barack Obama should be impeached and removed from office.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.